Literature DB >> 14559360

Gene expression profiling of melanocortin system in neuropathic rats supports a role in nociception.

Massimiliano Beltramo1, Marilena Campanella, Glauco Tarozzo, Silva Fredduzzi, Laura Corradini, Angelo Forlani, Rosalia Bertorelli, Angelo Reggiani.   

Abstract

The melanocortin (MC) system is involved in several biological functions. Its possible role in nociception has recently attracted attention in the field. Published data suggest that melanocortin antagonists are analgesic and agonists are hyperalgesic. Gene expression information about the MC system components (receptor, agonist and antagonist) in pain relevant areas is at present limited. To deepen our knowledge, we studied the expression of MC system components in nai;ve, sham and neuropathic rat spinal cord and dorsal root ganglia (DRG) by PCR and quantitative real-time PCR. MC4 receptor, proopiomelanocortin (POMC) and agouti-related protein (AgRP) transcripts were detected in both spinal cord and DRG, whereas MC3 receptor was detected only in the spinal cord. To study the relationship between the MC system and chronic pain, we used the chronic constriction injury model and gene expression analysis was performed in rats showing both tactile allodynia and thermal hyperalgesia. MC4 and POMC transcript were upregulated in the spinal cord of neuropathic rats, whereas MC3 and AgRP expression were unaffected. Thus, this study demonstrates for the first time the presence of AgRP in the spinal cord and DRG, suggesting that it could play a role in the regulation of MC system activity. In addition, the upregulation of POMC and MC4, in parallel with the presence of tactile allodynia and thermal hyperalgesia, further supports the idea of MC system involvement in nociception.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559360     DOI: 10.1016/j.molbrainres.2003.08.001

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  13 in total

1.  Melanocortin type 4 receptor-mediated inhibition of A-type K+ current enhances sensory neuronal excitability and mechanical pain sensitivity in rats.

Authors:  Yuan Zhang; Dongsheng Jiang; Hua Li; Yufang Sun; Xinghong Jiang; Shan Gong; Zhiyuan Qian; Jin Tao
Journal:  J Biol Chem       Date:  2019-02-11       Impact factor: 5.157

Review 2.  Synaptic changes induced by melanocortin signalling.

Authors:  Vanni Caruso; Malin C Lagerström; Pawel K Olszewski; Robert Fredriksson; Helgi B Schiöth
Journal:  Nat Rev Neurosci       Date:  2014-02       Impact factor: 34.870

3.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

4.  Melanocortin-4 receptor signaling in the central amygdala mediates chronic inflammatory pain effects on nociception.

Authors:  Nathan M Sharfman; Leslie K Kelley; Maria E Secci; Nicholas W Gilpin
Journal:  Neuropharmacology       Date:  2022-03-16       Impact factor: 5.273

5.  Control elements in the neighboring ATPase gene influence spatiotemporal expression of the human agouti-related protein.

Authors:  Olha Ilnytska; Mehmet A Sözen; Rachel Dauterive; George Argyropoulos
Journal:  J Mol Biol       Date:  2009-03-13       Impact factor: 5.469

Review 6.  The role of the Agouti-Related Protein in energy balance regulation.

Authors:  O Ilnytska; G Argyropoulos
Journal:  Cell Mol Life Sci       Date:  2008-09       Impact factor: 9.261

7.  Nicotine anxiogenic and rewarding effects are decreased in mice lacking beta-endorphin.

Authors:  José M Trigo; Andreas Zimmer; Rafael Maldonado
Journal:  Neuropharmacology       Date:  2009-04-17       Impact factor: 5.250

8.  Neuroprotective effects of melanocortins in experimental spinal cord injury. An experimental study in the rat using topical application of compounds with varying affinity to melanocortin receptors.

Authors:  H S Sharma; A Skottner; T Lundstedt; M Flärdh; L Wiklund
Journal:  J Neural Transm (Vienna)       Date:  2006-04       Impact factor: 3.575

9.  Role of SIP30 in the development and maintenance of peripheral nerve injury-induced neuropathic pain.

Authors:  Yu-Qiu Zhang; Ning Guo; Guangdun Peng; Xidao Wang; Mei Han; Jeremy Raincrow; Chi-hua Chiu; Lique M Coolen; Robert J Wenthold; Zhi-Qi Zhao; Naihe Jing; Lei Yu
Journal:  Pain       Date:  2009-09-12       Impact factor: 6.961

Review 10.  Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases.

Authors:  Lila Carniglia; Delia Ramírez; Daniela Durand; Julieta Saba; Juan Turati; Carla Caruso; Teresa N Scimonelli; Mercedes Lasaga
Journal:  Mediators Inflamm       Date:  2017-01-05       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.